Pharmacogenomics

Article	Citations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations	37
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN12	27
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing	26
Assessing patient understanding of pharmacogenomic test results: a qualitative study	24
How to implement pre-emptive pharmacogenetic testing in the acute hospital setting	23
Pharmacogenomic variants affecting efficacy and safety of medicines acting on central nervous system among Sri Lankans	22
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review	19
Patient comprehension of preemptive pharmacogenomic results	17
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization	16
Genetics and response to treatment with metformin for type 2 diabetes	15
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study	13
Rapid point of care testing: the next frontier in pharmacogenomics	12
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications	12
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report	12
CYP2D6 genotyping in a Korean cohort: comparative analysis with Asian, Caucasian, and African populations	11
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level	11
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates	11
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations	11
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study	10
Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor	10
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison	10
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy	9
Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention	9
A Survey of Physician Opinions in Russia in the Field of Pharmacogenetics of Cardiovascular Disease	9
Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam	8

Improving the Management of ALK-Rearranged Non-Small-Cell Lung Cancer Through a Mobile Application: A Physicians-Based Survey	8
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration	8
Genetic polymorphisms and adverse reactions to antituberculosis therapy	8
EFfects of UGT1A , CYP2C9/19 and ABAT Polymorphisms on Plasma Concentration of Valproic Acid in Chinese Epi	8
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study	8
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population	8
Genetika+: Precision Medicine Solutions for Mental Health	7
Impact of genetic variants on fentanyl metabolism in major breast surgery patients: a candidate gene association study	7
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics	7
A critical review of RAF inhibitors in BRAF-mutated glioma treatment	7
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma	7
Head-to-head Comparison of Various Antipsychotic Agents on Genome-Wide Methylation in Schizophrenia	7
Genetic Factors Associated with Tuberculosis-Related Clinical Outcomes in HIV-Infected Black African Patients: a Systematic Review and Meta-Analysis	7
UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety	7
Effects of CYP3A4 and CYP2C9 Genotype on Systemic Anastrozole and Fulvestrant Concentrations in SWOG S0226	6
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations	6
DDX11-AS1 Modulates Dna Damage Repair to Enhance Paclitaxel Resistance of Lung Adenocarcinoma Cells	6
TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience	6
SLCO1B1 and ABCB1 Variants Synergistically Influence the Atorvastatin Treatment Response in South Indian Coronary Artery Disease Patients	6
The Festival of Genetics and Personalized Medicine	6
Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review	6
Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data	6
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?	5
Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic Fibrosis	5
Predicting laboratory aspirin resistance in Chinese stroke patients using machine learning models by GP1BA polymorphism	5
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study	5
Polymorphisms of Genes Related to Phase II Metabolism and Resistance to Clopidogrel	5
XDH Genotypes Through Gene–Gene Interactions with NUDT15 Affect Azathioprine-Induced Leukopenia in Chinese Patients	5
Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message	5
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions	5
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation	5
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients	5
Glutathione S -transferase Gene Polymorphism and Asthma: A Case–Control Study in a Pediatric Population	5
Erratum	5
Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases	5
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants	5
Pharmacogenomics in Pediatric Medicine and Drug Development	5
Association between CYP3A4 , CYP3A5 and ABCB1 Genotype and Tacrolimus Treatment Outcomes Among Allogeneic H	5
Carbamazepine Cutaneous Adverse Reactions and HLA Gene Variation in the Chinese Population: A Systematic Review and Meta-Analysis	5
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability	5
Genetic polymorphisms of OPRM1 on the Efficacy and Safety of Anesthetic and Analgesic Agents: A Systematic Review	5
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing	4
Bioinformatic Tools are Essential to Integrating Pharmacogenomics into Clinical Practice: Lessons from Neuropsychiatric Disorders	4
Liquid biopsy: an essential tool for metastatic breast cancer’s follow-up	4
KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide	4
Single-Nucleotide Polymorphisms in ABC Drug Transporters Alter Expression and Circulating Tenofovir in Healthy South African Women Exposed to Pre-Exposure Prophylaxis	4
Clinical Pharmacology and Pharmacogenomics for Implementation of Personalized Medicine	4
Pharmacogenetics of HIV Therapy: Challenges for Tailoring Treatment in Genetically Complex Populations	4
Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients	4
Relevance of NAT2 Genotype and Clinical Factors to Risk for Antituberculosis Drug-Induced Liver Injury	4

Overview of the Year 2023 at Pharmacogenomics	4
Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis	4
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?	4
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice	4
Variation in the ABC transporter genes and association with clinical outcomes in colorectal cancer: a brief review	4
Dosage Optimization of Clopidogrel Via a Precision Medicine Approach: The Way Forward	4
Influence of CYP3A5 , IL-10 Polymorphisms and Metabolism Rate on Tacrolimus Exposure in Renal Post-Transplant Recipients	4
Pharmacogenomic curriculum in Australian medical schools: a content analysis study	4
Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital	4
Impact of ABCB1 gene polymorphism on clopidogrel plasma concentration and cardiovascular events in post-PCI patients	4
Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients	4
Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review	4
Psychiatric Level 1A Evidence Pharmacogenomics in a Brazilian Admixed Cohort and Global Populations	3
Analysis of the Difference in SLCO1B1 and APOE Gene Polymorphisms Between Mongolian and Han Populations	3
ABCB1 and OPRM1 Single-Nucleotide Polymorphisms Collectively Modulate Chronic Shoulder Pain and Dysfunction in South African Breast Cancer Survivors	3
Use of a Consultation Service Following Pharmacogenetic Testing in Psychiatry	3
Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer’s disease	3
Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ”	3
Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury	3
Congruence Rates for Pharmacogenomic Noninterruptive Alerts	3
Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management	3
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate	3
Pharmacogenetic Variants Influence Vitamin K Anticoagulant Dosing in Patients with Mechanical Prosthetic Heart Valves	3
Genetic Variants of the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Reaction Element Pathway on the Risk of Antituberculosis Drug-Induced Liver Injury: A Systematic Review	3
Targeting RET mutation in medullary thyroid cancer	3
Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary	3
Pharmacogenomic Variants Affecting Efficacy and Toxicity of Statins in a South Asian Population from Sri Lanka	3
lncRNA MALAT1 Regulates the Resistance of Breast Cancer Cells to Paclitaxel Via the miR-497-5p/ SHOC2 axis	3
Evaluation of Pentamidine Tolerability and Efficacy Between CYP2C19 Phenotypes	3
Leveraging Clinical Decision Support to Reduce the Risk of Discordant Pharmacogenomics Results	3
Artificial intelligence, medications, pharmacogenomics, and ethics	3
Influence of Polymorphisms in CYP2C9 , VKORC1 , MDR1 and APOE Genes on the W	3
Pharmacogenetic Informed Care in Early Childhood: Options for Improving Access and Health Equity	3
Pharmacoepigenomics: A Key Determinant in Resolving Epigenomic Parameters in Pathogenesis and Treatment Response in Complex Diseases	3
Validation of a Multi-Gene qPCR-Based Pharmacogenomics Panel Across Major Ethnic Groups in Singapore and Indonesia	3
The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review	3
Integrating Pharmacogenomic Testing Into Paired Germline and Somatic Genomic Testing in Patients with Cancer	3
ATP Binding Cassette Transporters and Cancer: Revisiting Their Controversial Role	3
Pharmacogenomics education among professional societies: assessing practices and future needs	3
Association of CYP2C19 , CYP3A4 and ABCC2 Polymorphisms and Voriconazole Plasma Concentrations in Uygur Ped	3
SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate	3
Genetic polymorphism associated with non-response to therapy in inflammatory bowel disease patients: a review	3
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients	3
Identification of Clinical and Pharmacogenetic Factors Influencing Metformin Response in Type 2 Diabetes Mellitus	2
Comparing the clinical utility of pharmacogenomic genotyping and next generation sequencing in a military health system adult medicine clinic	2
Warfarin Pharmacogenomics in African Populations: The Importance of Ethnicity-Based Algorithms	2
Breast Cancer Pharmacogenetics: A Systematic Review	2
Pharmacogenomics in Clinical Practice to Prevent Risperidone-Induced Hyperprolactinemia in Autism Spectrum Disorder	2
The Need to Shift Pharmacogenetic Research from Candidate Gene to Genome-Wide Association Studies	2
Pharmacogenetic and Pharmacogenomic Treatment of Rheumatoid Arthritis: A Review of Pharmacogenomics Knowledge Base Scientific Evidence	2
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms	2
IL16 and Factor V Gene Variations are Associated with Asparaginase-Related Thrombosis in Childhood Acute Lymphoblastic Leukemia Patients	2
Pharmacogenetics Research in Brazil: A Systematic Review	2
Implication of KDM6A in Bladder Cancer	2
Premarket Assessment of Molecular Alterations in Drug Targets: A Case Study of 2020 Drug Approvals	2
An Interview with Dr Chiara Fabbri: Pharmacogenomics and Drug Repurposing for Treatment-Resistant Depression	2
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity	2
Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse Events	2
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review	2
Association of Polymorphisms in ARRB2 and Clinical Response to Methadone for Pain in Advanced Cancer	2
Effects of MDR1 and OPRM1 Genetic Polymorphisms on the Pharmacodynamics of Propofol–Remifentanil TIVA in Pediatrics	2
Pharmacogenetics of 6-Mercaptopurine in a Black Zimbabwean Cohort Treated for Acute Lymphoblastic Leukaemia	2
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel	2
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing	2
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada	2
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress	2
Parental Understanding and Attitudes Following Pharmacogenomic Testing for Pediatric Neuropsychiatric Patients	2
TPMT Gene Polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a Healthy Venezuelan Population	2
Pharmacogenetic Differentiation Across Latin America	2
The genomic landscape of CYP2D6 variation in the Indian population	2
Considering Medication Exposure in Genomic Association Studies of Cognition in Psychotic Disorders	2
Antiplatelet Therapy Guided by CYP2C19 Point-of-Care Pharmacogenetics Plus Multidimensional Treatment Decisions	2
Pharmacogenetic Loci for Rosuvastatin are Associated with Intima-Media Thickness Change and Coronary Artery Disease Risk	2
Whole-exome Sequencing Reveals Novel Candidate Single Nucleotide Variations for Preventing Adverse Effects of Levonorgestrel Implantation	2
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro	2
SLCO1B3 T334G Polymorphisms and Mycophenolate Mofetil-Related Adverse Reactions in Kidney Transplant Recipients	2
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites	2
Pharmacogenomics of Hydroxyurea Therapy and Fetal Hemoglobin Levels in Sickle Cell Anemia	2
Real-world evaluation of CYP2C19 guided antiplatelet therapy in patients undergoing intracranial aneurysm repair	1
Pharmacogenomics Implementation Across Multiple Clinic Settings: A Qualitative Evaluation	1

Pharmacogenetics of Clopidogrel and Warfarin in the Treatment of Cardiovascular Diseases: An Overview of Reviews	1
Application of Pharmacogenomics in Supportive Oncology: A Patient Journey	1
Building an Information System to Facilitate Pharmacogenomics Clinical Translation with Clinical Decision Support	1
HLA Pharmacogenetic Markers of Drug Hypersensitivity from the Perspective of the Populations of the Greater Middle East	1
Clinical Pharmacogenomics Implementation In Thailand: A Dream Come True	1
Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty	1
rs144012689 is a Highly Specific Representative Marker of HLA-B*15:02 in the Chinese Population	1
Application of Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma	1
Frequency and Impact of DHODH, ABCG2 and CYP2C19 SNPs on the Therapeutic Efficacy, Tolerability and Toxicity of Leflunomide	1
Treatment of extended RAS/ BRAF wild-type metastatic colorectal cancer with anti-EGFR antibody combinations	1
Association of OPRK1 rs963549 and rs997917 Polymorphisms With Opioid Use Disorder and Related Phenotypes	1
PMAT Variant Rs3889348 is Associated with Metformin-Induced Gastrointestinal among Chinese Type 2 Diabetes Patients	1
Survey of the utilization of genotype-guided tacrolimus management in United States solid organ transplant centers	1
An Alcohol Dehydrogenase 7 Gene Polymorphism Associates with Both Acute and Chronic Pain in Sickle Cell Disease	1
Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism	1
AGO2 Expression Levels and Related Genetic Polymorphisms: Influence in Renal Cell Progression and Aggressive Phenotypes	1
Pharmacogenomics of Oxcarbazepine in the Treatment of Epilepsy	1
Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention	1
Sertraline Dosing Trends in Children and Adolescents Stratified by CYP2C19 Genotype	1
HLA-B*57:01 Typing in a Malaysian Cohort: Implications of Abacavir Hypersensitivity in People Living with HIV	1
Personalized Anti-Rejection Therapy with Alemtuzumab for Kidney Transplant Recipients	1
Providers’ use of pharmacogenetic testing to inform opioid prescribing among veterans	1
Impact of CYP2C19 polymorphism testing on the risk of stent thrombosis in patients with carotid artery stenting	1
Predicting nifedipine responses in preterm labor: a risk score incorporating ABCG2 polymorphisms and clinical factors	1
Pharmacogenomics of Medications Given Via Nonconventional Administration Routes: A Scoping Review	1
Coriell Life Sciences: Empowering the Most Precise Medical Care for a Healthier World	1
Impact of the PEAR 1 Polymorphism on Clinical Outcomes in Chinese Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Interventio	1
Pharmacogenetics of Pain Management in Zimbabwean Patients With Sickle Cell Disease	1
HLA-DRB1 *16:02 is Associated with PEG-Asparaginase Hypersensitivity	1
Impact of Genetic Polymorphisms on Tacrolimus Trough Blood Concentration in Chinese Liver Transplant Recipients	1
Circulating Tumor DNA-Guided Minimal Residual Disease Assessment in Colorectal Cancer	1
Screening and analysis of single nucleotide polymorphism in the 3′-UTR microRNA target regions and its implications for lung tumorigenesis	1
Transcriptional Effects of Fingolimod Treatment on Peripheral T Cells in Relapsing Remitting Multiple Sclerosis Patients	1
Profiling of Pharmacogenomic Variants in CYP2D6 and DPYD in Indigenous Arab Breast Cancer Patients	1
Pharmacogenomic Markers of Metoprolol and α-OH-Metoprolol Concentrations: A Genome-Wide Association Study	1
Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder	1
Towards Next-Generation Personalization of Tacrolimus Treatment: a Review on Advanced Diagnostic and Therapeutic Approaches	1
The Association Between HLA-B*15:02 and Phenytoin-Induced Severe Cutaneous Adverse Reactions: A Meta-Analysis	1
CYP2C18: The Orphan in the CYP2C Family	1
ARG2 Single-Nucleotide Polymorphism RS3742879 Affects Plasma Arginase 2 Levels, Nitric Oxide Formation and Antihypertensive Therapy Response in Preeclampsia	1
Scoping review of associations between cytochrome P450 3A4/5 single nucleotide polymorphisms and risk factors for fentanyl overdose	1
A Single-Tube Multiplex Real-Time PCR for HLA-B*38:02 Genotype by Detecting Highly Specific SNPs	1
Challenges for the Application of Pharmacogenomics Associated with the Nomenclature of Allelic Variants	1
From bench to bedside: a spotlight on pharmacogenomics at Nemours Children’s Health	1
Pharmacogenomics and Clinical Cultural Competency: Pathway to Overcome the Limitations of Race	1
SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma	1
The Role of Alcohol Intake in the Pharmacogenetics of Treatment with Clozapine	1
Ethnic differences in pharmacogenomic variants: a south Asian perspective	1
PGxKnow: A Pharmacogenomics Educational Hololens Application of Augmented Reality and Artificial Intelligence	1
A genome-wide association study of stroke risk in Asian statin users: evidence from KoGES and UK Biobank	1
Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease	1
Diversity of Pharmacogenomic Variants Affecting Warfarin Metabolism in Sri Lankans	1
Pharmacogenetics to optimize immunosuppressant therapy in systemic lupus erythematosus: a scoping review	1
Diagnosis and Treatment Monitoring in Breast Cancer: How Liquid Biopsy Can Support Patient Management	1